The central question of my research group is "how to treat brain metabolic dysfunctions associated with neurological disorders?"

I have built an internationally renowned expertise in rare human diseases that primarily affect brain metabolic pathways. My group has developed an original therapeutic approach that targets the Krebs cycle in order to correct brain energy deficiency. We use various metabolic technologies (in vivo metabolic imaging, metabolomics, lipidomics) to characterize brain metabolic dysfunctions in neurodegenerative diseases.